Sign Up to like & get
recommendations!
0
Published in 2018 at "Current problems in cancer"
DOI: 10.1016/j.currproblcancer.2018.01.011
Abstract: Leiomyosarcomas (LMS) are rare tumors with poor prognosis owing to the high rate of recurrent and metastatic disease. The combination of doxorubicin (Adriamycin) plus ifosfamide and mesna (AIM) results in moderate response rates of 10%-30%.…
read more here.
Keywords:
doxorubicin treatment;
treatment;
treatment advanced;
aim regimen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-15200-3
Abstract: While impressive improvements have been achieved in T-ALL therapy, current treatment approaches fail in approximately 25% of patients and these patients have limited treatment options. Another significant group of patients is being overtreated, which causes…
read more here.
Keywords:
doxorubicin treatment;
ephb6 receptor;
treatment;
sensitivity ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2022 at "Journal of Healthcare Engineering"
DOI: 10.1155/2022/7995385
Abstract: In this article, we have compared and analyzed the clinical effects of temozolomide single agent and combined doxorubicin in the treatment of glioma. To evaluate this, a total of 70 patients diagnosed with glioma in…
read more here.
Keywords:
group;
doxorubicin treatment;
treatment;
temozolomide single ... See more keywords
Sign Up to like & get
recommendations!
2
Published in 2022 at "Journal of the American Veterinary Medical Association"
DOI: 10.2460/javma.21.11.0498
Abstract: OBJECTIVE To evaluate the efficacy of doxorubicin for treatment of histiocytic sarcoma (HS) in dogs, whether administered as the sole treatment or as an adjunct to surgery or radiation therapy. ANIMALS 31 client-owned dogs with…
read more here.
Keywords:
histiocytic sarcoma;
2003 2017;
sarcoma dogs;
treatment ... See more keywords